InvestorsHub Logo
Followers 17
Posts 1755
Boards Moderated 0
Alias Born 11/13/2013

Re: ekopolitik post# 29907

Friday, 06/27/2014 9:13:12 AM

Friday, June 27, 2014 9:13:12 AM

Post# of 429029
No script growth for Vascepa, yet Lovaza TRx was up 15% and NRx up 19%. This continues to disturb me. Vascepa is a superior product. Absent Anchor approval, Amarin needs to dominate the market for the Marine indication. So far, their performance in that arena has been abysmal.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News